104 related articles for article (PubMed ID: 35121129)
1. Lipophagy-Related Protein Perilipin-3 and Resistance of Prostate Cancer to Radiation Therapy.
Lamprou I; Kakouratos C; Tsolou A; Pavlidis P; Xanthopoulou ET; Nanos C; Tsaroucha A; Sivridis E; Giatromanolaki A; Koukourakis MI
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):401-414. PubMed ID: 35121129
[TBL] [Abstract][Full Text] [Related]
2. Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine.
Lamprou I; Tsolou A; Kakouratos C; Mitrakas AG; Xanthopoulou ET; Kassela K; Karakasiliotis I; Zois CE; Giatromanolaki A; Koukourakis MI
Med Oncol; 2021 Aug; 38(10):116. PubMed ID: 34410522
[TBL] [Abstract][Full Text] [Related]
3. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
Zhou L; Song Z; Hu J; Liu L; Hou Y; Zhang X; Yang X; Chen K
Theranostics; 2021; 11(2):841-860. PubMed ID: 33391508
[TBL] [Abstract][Full Text] [Related]
4. A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis.
Garcia-Macia M; Santos-Ledo A; Leslie J; Paish HL; Collins AL; Scott RS; Watson A; Burgoyne RA; White S; French J; Hammond J; Borthwick LA; Mann J; Bolaños JP; Korolchuk VI; Oakley F; Mann DA
Hepatology; 2021 Dec; 74(6):3441-3459. PubMed ID: 34233024
[TBL] [Abstract][Full Text] [Related]
5. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
[TBL] [Abstract][Full Text] [Related]
6. High glucose, insulin and free fatty acid concentrations synergistically enhance perilipin 3 expression and lipid accumulation in macrophages.
Fan B; Gu JQ; Yan R; Zhang H; Feng J; Ikuyama S
Metabolism; 2013 Aug; 62(8):1168-79. PubMed ID: 23566650
[TBL] [Abstract][Full Text] [Related]
7. Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissue.
Fontaine A; Bellanger D; Guibon R; Bruyère F; Brisson L; Fromont G
J Pathol; 2021 Oct; 255(2):166-176. PubMed ID: 34219239
[TBL] [Abstract][Full Text] [Related]
8. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
[TBL] [Abstract][Full Text] [Related]
9. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
[TBL] [Abstract][Full Text] [Related]
10. PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.
Wang K; Ruan H; Song Z; Cao Q; Bao L; Liu D; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Yang H; Chen K; Zhang X
Urol Oncol; 2018 Jul; 36(7):343.e9-343.e19. PubMed ID: 29773494
[TBL] [Abstract][Full Text] [Related]
11. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
Robichaud S; Fairman G; Vijithakumar V; Mak E; Cook DP; Pelletier AR; Huard S; Vanderhyden BC; Figeys D; Lavallée-Adam M; Baetz K; Ouimet M
Autophagy; 2021 Nov; 17(11):3671-3689. PubMed ID: 33590792
[TBL] [Abstract][Full Text] [Related]
13. Plin3 protects against alcoholic liver injury by facilitating lipid export from the endoplasmic reticulum.
Gu Y; Yang Y; Cao X; Zhao Y; Gao X; Sun C; Zhang F; Yuan Y; Xu Y; Zhang J; Xiao L; Ye J
J Cell Biochem; 2019 Sep; 120(9):16075-16087. PubMed ID: 31119787
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells.
Chen C; Wang K; Wang Q; Wang X
Braz J Med Biol Res; 2018; 51(6):e7080. PubMed ID: 29694502
[TBL] [Abstract][Full Text] [Related]
15. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A
Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
17. Changes in mitochondrial perilipin 3 and perilipin 5 protein content in rat skeletal muscle following endurance training and acute stimulated contraction.
Ramos SV; Turnbull PC; MacPherson RE; LeBlanc PJ; Ward WE; Peters SJ
Exp Physiol; 2015 Apr; 100(4):450-62. PubMed ID: 25663294
[TBL] [Abstract][Full Text] [Related]
18. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
[TBL] [Abstract][Full Text] [Related]
19. PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells.
Yao B; Liu B; Shi L; Li X; Ren C; Cai M; Wang W; Li J; Sun Y; Wu Y; Wen J
Oncotarget; 2017 Feb; 8(8):13846-13854. PubMed ID: 28099922
[TBL] [Abstract][Full Text] [Related]
20. Combined targeting of EGFR and HER2 against prostate cancer stem cells.
Rossini A; Giussani M; Ripamonti F; Aiello P; Regondi V; Balsari A; Triulzi T; Tagliabue E
Cancer Biol Ther; 2020 May; 21(5):463-475. PubMed ID: 32089070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
